Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AILSE:MPAL EV-to-EBIT is -4.55 as of Aug. 04, 2026. The stock has 1 warning sign investors should review. Among 470 Healthcare Providers & Services companies, MedPal AI ranks worse than 212765.74% on this metric.
The historical rank and industry rank for MedPal AI's EV-to-EBIT or its related term are showing as below:
LSE:MPAL'
s EV-to-EBIT Range Over the Past 10 Years
Min: -5.05 Med: 0 Max: 0
Current: -4.55
LSE:MPAL's EV-to-EBIT is ranked worse than 100% of 470
companies
in the Healthcare Providers & Services industry
Industry Median: 16.025
vs LSE:MPAL: -4.55
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
MedPal AI's Enterprise Value for the quarter that ended in Feb. 2026 was £20.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was £-5.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI EV-to-EBIT Related Terms
MedPal AI EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for MedPal AI's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:MPAL vs VEEV, BTSG, HQY: EV-to-EBIT Comparison
For the Health Information Services subindustry, MedPal AI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where MedPal AI's EV-to-EBIT falls into.
MedPal AI's current Enterprise Value is £24.61 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MedPal AI's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was £-5.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI (LSE:MPAL) has a EV-to-EBIT of -4.55 as of Aug. 04, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on MedPal AI and its competitors. According to the industry distribution chart, MedPal AI ranks #999999 out of 470 companies in the Healthcare Providers & Services industry.
Is MedPal AI's EV-to-EBIT too high?
MedPal AI's current EV-to-EBIT is -4.55. Based on the distribution chart, MedPal AI ranks #999999 out of 470 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does MedPal AI's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #999999 out of 470 companies for EV-to-EBIT. This places MedPal AI in the lower half of its industry. The industry median EV-to-EBIT is 16.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 16.03, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 16.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current EV-to-EBIT is -4.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current EV-to-EBIT of -4.55. The current EV-to-EBIT is -4.55. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current EV-to-EBIT is -4.55 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
